Ardelyx reported $127.27M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Amgen USD 4.78B 1.12B Mar/2026
Ardelyx USD 127.27M 7.15M Mar/2026
aTyr Pharma USD 2.42M 83.19M Mar/2026
Corcept Therapeutics USD 214.5M 16.87M Mar/2026
Curis USD 9.02M 23.01M Dec/2025
Sanofi EUR 8.98B 1.73B Mar/2026
TG Therapeutics USD 170.12M 28.04M Mar/2026
United Therapeutics USD 5.9B 5.1B Mar/2026
Xoma USD 22.84M 1.67M Sep/2024